Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
09/24/1996 | US5559152 Pharmaceutical composition having antiacoholic activity |
09/24/1996 | US5559125 Nmda and ampa receptor antagonists, schizophrenia |
09/24/1996 | US5559096 Pharmaceutical compositions against gastric disorders |
09/24/1996 | US5559022 Liver reserve cells |
09/24/1996 | CA2026418C Polypeptides useful as blockers of calcium channels |
09/19/1996 | WO1996028467A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition |
09/19/1996 | WO1996028424A1 Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity |
09/19/1996 | WO1996028177A1 Method and vaccine for prevention of over-production of acid in the rumen or gut of animals |
09/19/1996 | WO1996028167A1 Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6 |
09/19/1996 | WO1996028148A2 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer |
09/19/1996 | WO1996028144A1 Use of ketorolac for treatment of squamous cell carcinomas of the oral cavity or oropharynx |
09/19/1996 | WO1996017936A3 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
09/18/1996 | EP0732334A1 Piperidine derivatives, process for their preparation and their therapeutic application |
09/18/1996 | EP0732333A1 Indazolecarboxamides |
09/18/1996 | EP0731790A1 Tachykinin antagonists |
09/18/1996 | EP0731712A1 Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
09/18/1996 | EP0731706A1 Use of dimeticone for treating aphthae and stomatitis |
09/18/1996 | EP0731705A1 Use of dimeticone for treating constipation |
09/18/1996 | EP0731696A1 Cysteine protease inhibitors containing heterocyclic leaving groups |
09/18/1996 | EP0666855B1 4-quinolinyl derivatives with anti-helicobacter activity |
09/18/1996 | EP0465677B1 Lactobacillus acidophilus f-133, lactic acid bacterium preparation prepared therefrom, and process for preparing the same |
09/18/1996 | CN1131392A Nitric oxide donor composition and method for treatment of anal disorders |
09/18/1996 | CN1131155A New tricyclic oxime ethers, processes for their preparation and pharmaceutical compositions containing them |
09/18/1996 | CN1131144A Glycinamide derivatives, processes for their preparation and medicines containing them |
09/18/1996 | CN1131041A Soft gelatin pharmaceutical dosage form |
09/17/1996 | US5556870 Use of leflunomide for inhibiting interleukin 1 beta |
09/17/1996 | US5556863 Antiinflammatory agents and antisecretory agents for gastric juice |
09/17/1996 | US5556862 Pharmaceutical compositions containing isoquinoline derivatives |
09/17/1996 | US5556855 N-heterocyclic substituted salicylic acids |
09/17/1996 | US5556851 Treatment of nausea or emesis from anticancer drugs or x-ray treatment |
09/17/1996 | US5556845 11-β substituted-19-nor steroids |
09/17/1996 | CA2086763C Sewing machine needle and method for manufacturing same |
09/17/1996 | CA2047027C Tablet and granulate containing mesna as active substance |
09/17/1996 | CA1338599C Imidazole derivatives |
09/14/1996 | CA2171579A1 Piperidine derivatives, process for the preparation thereof and application thereof in therapeutics |
09/12/1996 | WO1996027593A1 Arginine analogues having nitric oxide synthase inhibitor activity |
09/12/1996 | WO1996027583A1 Arylsulfonylamino hydroxamic acid derivatives |
09/12/1996 | WO1996027368A1 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate |
09/12/1996 | WO1996021468A3 Chemically modified interferon |
09/12/1996 | WO1996016677A3 Use of metal complexes as liver and gall bladder radiodiagnosis agents in computer tomography |
09/11/1996 | EP0731099A1 N-(3-benzofuranyl)urea-derivatives |
09/11/1996 | EP0730868A1 Formulated medicines for treatment of oral inflammation, and processed foods to treat and prevent stomatitis |
09/11/1996 | EP0730601A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
09/11/1996 | EP0730594A1 NOVEL 9-HYDROXY-PYRIDO [1,2-a]PYRIMIDIN-4-ONE ETHER DERIVATIVES |
09/11/1996 | EP0730470A1 Improved interferon polymer conjugates |
09/11/1996 | EP0730465A1 Use of angiotensin iii and analogs thereof in tissue repair |
09/11/1996 | EP0730464A1 Composition comprising sulcralfate and an antimicrobial agent/ion-exchange resin complex |
09/11/1996 | EP0730447A1 Fatty acid delivery system |
09/11/1996 | EP0450066B1 Carbostyril derivatives |
09/11/1996 | EP0372031B1 Biosynthetic osteogenic proteins and osteogenic devices containing them |
09/11/1996 | CN1130874A Method of treating liver disease and like indications with vasodilating agents |
09/11/1996 | CN1130866A Anti-angiogenic compositions and method of use |
09/11/1996 | CN1130631A Cyclodlkano-indole and-azaindole derivatives |
09/11/1996 | CN1130515A Chinese drug for treating chronic colitis |
09/10/1996 | US5554772 N-(3-hydroxy-4-piperidinyl) dihydrobenzofuran, (dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
09/10/1996 | US5554643 Pro-drugs for CCK antagonists |
09/10/1996 | US5554641 Nonpeptides as tachykinin antagonists |
09/10/1996 | US5554631 5-pyrrolyl-6-halogeno-2-pyridylmethylsulfinyl benzimidazole derivatives |
09/10/1996 | US5554621 Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives |
09/07/1996 | CA2170824A1 N-(3-benzofuranyl)urea-derivatives |
09/06/1996 | WO1996026937A1 Prokinetic oxadiazoles |
09/06/1996 | WO1996026931A1 Optically active thiazolidinone derivatives |
09/06/1996 | WO1996026737A1 Morphogen-induced dentine regeneration |
09/06/1996 | WO1996026707A1 Composition for hygiene, prophylaxis and treatment of the oral cavity |
09/06/1996 | CA2214341A1 Morphogen-induced dentine regeneration |
09/04/1996 | EP0729468A1 Non-peptide tachykinin receptor antagonists |
09/04/1996 | EP0729360A1 Treatment or prevention of crohn's disease and/or ulcerative colitis |
09/04/1996 | EP0729325A1 Osteogenic product and process |
09/04/1996 | EP0729297A1 Hepatoblasts and method of isolating same |
09/04/1996 | CN1130084A Oral administration paste for curing senile constipation |
09/03/1996 | US5552553 N-(3-hydroxy-4-piperidinyl) (dihydrobenzofuran, dihydro-2H-benzopyran or dehydrobenzodioxin) carboxamide derivatives |
09/03/1996 | US5552520 Such as somatostatin analogs or bombesin analogs |
09/03/1996 | US5552439 Aminophenol derivatives |
09/03/1996 | US5552421 Leukotriene biosynthesis inhibitors |
09/03/1996 | US5552418 Trisubstituted Naphthylalkylamides |
09/03/1996 | US5552404 Compounds for neurotransmitters for animals |
09/03/1996 | US5552403 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
08/29/1996 | WO1996026284A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |
08/29/1996 | WO1996026183A1 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists |
08/29/1996 | WO1996026180A1 Novelly substituted dtpa derivatives, metal complexes thereof, pharmaceuticals containing these complexes, diagnostic and therapeutic uses thereof and methods for preparing the complexes and pharmaceuticals |
08/29/1996 | WO1996025940A1 Composition for the treatment of diarrhea, its use and its preparation |
08/29/1996 | WO1996025936A1 2,6-diaryl pyridazinones with immunosuppressant activity |
08/29/1996 | WO1996025916A1 Method for preparing a preparation for bleaching teeth or for treating skin complaints and mucous membrane disorders |
08/29/1996 | CA2213689A1 Carbonated solutions for treating, mineralizing and fluoridating calcified tissues and methods for their use |
08/29/1996 | CA2213610A1 Ingap protein involved in pancreatic islet neogenesis |
08/29/1996 | CA2213454A1 Dtpa derivatives substituted in a novel way, their metal complexes, pharmaceutical agents containing these complexes, their use in diagnosis and therapy, as well as process for the production of complexes and agents |
08/29/1996 | CA2213135A1 2,6-diaryl pyridazinones with immunosuppressant activity |
08/29/1996 | CA2212106A1 Composition for the treatment of diarrhea, its use and its preparation |
08/29/1996 | CA2211435A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |
08/28/1996 | EP0728759A1 Heterocyclic compounds |
08/28/1996 | EP0728755A1 Thiophene compounds, process for their preparation and pharmaceutical compositions containing them |
08/28/1996 | EP0728747A1 Imidazole derivative, pharmaceutically acceptable salt thereof, process of manufacture therefor, and anti-ulcer drug including such derivative or salt |
08/28/1996 | EP0728148A1 Improved immunogenic compositions against human gastrin 17 |
08/28/1996 | EP0728147A1 Receptor specific atrial natriuretic peptides |
08/28/1996 | EP0728145A1 Endothelin receptor antagonists |
08/28/1996 | EP0728144A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases |
08/28/1996 | EP0728134A1 6-oxo-nucleosides useful as immunosuppressants |
08/28/1996 | EP0728128A1 Substituted phenyl compounds |
08/28/1996 | EP0727995A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists |
08/28/1996 | CN1129937A Indoline derivatives as 5HT2C antagonists |